Brief: Knight Therapeutics Announces Relaunch Of Onicit® In Brazil And Mexico
07/05/2025 12:34
Knight Therapeutics Inc GUD.TO: KNIGHT THERAPEUTICS ANNOUNCES RELAUNCH OF ONICIT® IN BRAZIL AND MEXICO Source text: ID:nGNX7n56Cx Further company coverage: GUD.TO
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil